These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27659287)

  • 1. Emerging role of ivabradine for rate control in atrial fibrillation.
    Turley SL; Francis KE; Lowe DK; Cahoon WD
    Ther Adv Cardiovasc Dis; 2016 Dec; 10(6):348-352. PubMed ID: 27659287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
    Verrier RL; Sobrado MF; Pagotto VP; Kanas AF; Machado AD; Varone BB; Sobrado LF; Nearing BD; Zeng D; Belardinelli L
    Heart Rhythm; 2013 Nov; 10(11):1692-7. PubMed ID: 23933296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D; Borer JS
    Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation.
    Wongcharoen W; Ruttanaphol A; Gunaparn S; Phrommintikul A
    Int J Cardiol; 2016 Dec; 224():252-255. PubMed ID: 27661415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S; Ebelt H; Hoke RS; Krummenerl A; Wienke A; Müller-Werdan U; Werdan K
    Clin Res Cardiol; 2011 Oct; 100(10):915-23. PubMed ID: 21638157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L; Simonsen U; Grimm D; Hedegaard ER
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with ivabradine in transgenic atrial fibrillation mice counteracts hyperpolarization-activated cyclic nucleotide gated channel overexpression.
    Wang J; Yang YM; Li Y; Zhu J; Lian H; Shao XH; Zhang H; Fu YC; Zhang LF
    J Cardiovasc Electrophysiol; 2019 Feb; 30(2):242-252. PubMed ID: 30302853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation.
    Verrier RL; Bonatti R; Silva AF; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
    Heart Rhythm; 2014 Dec; 11(12):2288-96. PubMed ID: 25111327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project.
    Fontenla A; López-Gil M; Tamargo-Menéndez J; Matía-Francés R; Salgado-Aranda R; Rey-Blas JR; Miracle-Blanco Á; Mejía-Martínez E; Pastor-Fuentes A; Toquero-Ramos J; Arias MÁ; Montilla I; Gómez de la Cámara A; Arribas F;
    Rev Esp Cardiol (Engl Ed); 2020 May; 73(5):368-375. PubMed ID: 31631048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation.
    Li YD; Ji YT; Zhou XH; Jiang T; Hong YF; Li JX; Xing Q; Xiong J; Yusufuaji Y; Tang BP
    Med Sci Monit; 2015 May; 21():1414-20. PubMed ID: 25982136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular Disease.
    Nawarskas JJ; Bowman BN; Anderson JR
    Cardiol Rev; 2015; 23(4):201-11. PubMed ID: 25839989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ivabradine: in adults with chronic heart failure with reduced left ventricular ejection fraction.
    Perry CM
    Am J Cardiovasc Drugs; 2012 Dec; 12(6):415-26. PubMed ID: 23181944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine for controlling heart rate in permanent atrial fibrillation: A translational clinical trial.
    Fontenla A; Tamargo J; Salgado R; López-Gil M; Mejía E; Matía R; Toquero J; Montilla I; Rajjoub EA; García-Fernandez FJ; Miracle A; Rey JR; Bueno H;
    Heart Rhythm; 2023 Jun; 20(6):822-830. PubMed ID: 37245897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.
    Verrier RL; Silva AF; Bonatti R; Batatinha JA; Nearing BD; Liu G; Rajamani S; Zeng D; Belardinelli L
    J Cardiovasc Electrophysiol; 2015 Mar; 26(3):329-35. PubMed ID: 25346368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
    Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biological effects of ivabradine in cardiovascular disease.
    Speranza L; Franceschelli S; Riccioni G
    Molecules; 2012 Apr; 17(5):4924-35. PubMed ID: 22547315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
    Abdel-Salam Z; Rayan M; Saleh A; Abdel-Barr MG; Hussain M; Nammas W
    Cardiol J; 2015; 22(2):227-32. PubMed ID: 25179314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.
    Koncz I; Szél T; Jaeger K; Baczkó I; Cerbai E; Romanelli MN; Gy Papp J; Varró A
    Curr Med Chem; 2011; 18(24):3662-74. PubMed ID: 21774761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N; Bhargava B
    Am J Cardiovasc Drugs; 2011; 11(1):1-12. PubMed ID: 21090826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.